|
|
||||||||||||||
|
|
|||||||||||||||
|
British Journal of Ophthalmology 2005;89:960-963; doi:10.1136/bjo.2004.053397 Copyright © 2005 by the BMJ Publishing Group Ltd.
Systemic hypertension and glaucoma: mechanisms in common and co-occurrenceM J S Langman1, R J Lancashire2, K K Cheng2, P M Stewart1
1 Department of Medicine, University of Birmingham, Birmingham, UK
Correspondence to:
Methods: Case-control study using general practitioner database of patients with glaucoma matched with controls for age and sex. Results: Hypertension was significantly more common in the 27 080 patients with glaucoma (odds ratio 1.29, 95% confidence intervals 1.23 to 1.36, p<0.001) than in controls. Treatment by oral ß blockade appeared to protect from risk (odds ratio 0.77, 95% CI 0.73 to 0.83, p<0.0001), but oral calcium channel antagonists or angiotensin converting enzyme (ACE) inhibitors did not (odds ratios 1.34, 1.24 to 1.44 and 1.16 1.091.24, respectively, p<0.0001 in each case). Oral corticosteroid treatment was associated with enhanced risk (odds ratio 1.78, 1.61 to 1.96). Conclusion: Common pathogenetic mechanisms in ciliary and renal tubular epithelia may explain coincidence of glaucoma and systemic hypertension. The choice of cardiovascular treatment, could substantially influence glaucoma incidence, with ß blockade protecting and ACE inhibitors or calcium channel blockers not affecting underlying risk.
Abbreviations: ACE, angiotensin converting enzyme; GPRD, General Practitioner Research Database Keywords: glaucoma; hypertension; ß blockade; sodium transport
Relevant Article
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |